Science Explorer Back to mapMap
Discussion
Topic · Oncology

Cancer Diagnosis and Treatment

Cancer Diagnosis and Treatment is a research topic within Oncology. Science Explorer counts 41k research works in it since 1950. 10.4% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis, treatment, and molecular characterization of Cancer of Unknown Primary (CUP) site. It includes research on metastatic patterns, molecular profiling to identify tissue of origin, immunohistochemical markers, diagnostic algorithms, and clinical management strategies.

  • Cancer of Unknown Primary
  • Metastasis
  • Tissue of Origin
  • Molecular Profiling
  • Immunohistochemistry
  • Diagnostic Algorithm
  • Soft Tissue Metastases
  • Gene Expression Profiling
  • Unknown Primary Tumours
  • Clinical Management
Research works
41k
fractional, since 1950
In the world top 10%
4.3k
per year above
Top-10% rate
10.4%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-9%
the tick is no change
Largest producer
United States
33% of the 10 largest, 2022-now

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Cancer Diagnosis and Treatment research?

By volume, the United States and China publish the most (1.4k and 638 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.4k works
  2. 2 China 638 works
  3. 3 India 513 works
  4. 4 Japan 457 works
  5. 5 United Kingdom 275 works
  6. 6 Germany 235 works
  7. 7 Italy 198 works
  8. 8 Spain 184 works
  9. 9 Brazil 172 works
  10. 10 Türkiye 164 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 33.1%China: 15.1%India: 12.1%Japan: 10.8%6 others listed: 29.0%33%largest
United States1,401 · 33.1%China638 · 15.1%India513 · 12.1%Japan457 · 10.8%6 others listed1,228 · 29.0%

Shares of the rows listed above, not of the whole node.

Which institutions lead Cancer Diagnosis and Treatment research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Cancer Diagnosis and Treatment research, followed by Harvard University and The University of Texas MD Anderson Cancer Center.

Who are the leading researchers in Cancer Diagnosis and Treatment?

The most-cited researchers publishing on Cancer Diagnosis and Treatment include Ahmedin Jemal, Eric S. Lander and Elaine R. Mardis.

  1. 1 Ahmedin Jemal United States 761k citations
  2. 2 Eric S. Lander United States 524k citations
  3. 3 Elaine R. Mardis United States 346k citations
  4. 4 Hermann Brenner Germany 343k citations
  5. 5 Cyrus Cooper United Kingdom 342k citations
  6. 6 Robert A. Weinberg United States 301k citations
  7. 7 Todd R. Golub United States 283k citations
  8. 8 Reza Malekzadeh Iran 278k citations
  9. 9 Gordon Brent Mills United States 265k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Cancer Diagnosis and Treatment?

The most cited paper in Cancer Diagnosis and Treatment is "The 2015 World Health Organization Classification of Lung Tumors" (William David Travis, Elisabeth M. Brambilla, Andrew Gordon Nicholson et al., 2015), with 4,651 citations. Next come "Head and neck squamous cell carcinoma" (4,223) and "Mesenchymal stem cells within tumour stroma promote breast cancer metastasis" (3,235).

Most cited papers
#PaperReleasedCitations
1 The 2015 World Health Organization Classification of Lung Tumors William David Travis, Elisabeth M. Brambilla, Andrew Gordon Nicholson et al. · Journal of Thoracic Oncology Open access 21 Aug 2015 4,651
2 Head and neck squamous cell carcinoma Daniel E. Johnson, Barbara Ann Burtness, Charles René Leemans et al. · Nature Reviews Disease Primers ReviewOpen access 26 Nov 2020 4,223
3 Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Antoine E. Karnoub, Ajeeta B. Dash, Annie P. Vo et al. · Nature 3 Oct 2007 3,235
4 American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update Salvatore L. Ruggiero, Thomas B. Dodson, John E Fantasia et al. · Journal of Oral and Maxillofacial Surgery 5 May 2014 2,926
5 Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity Robert Edward Coleman · Clinical Cancer Research 15 Oct 2006 2,508
All 100 most cited papers, with filters and sorting

Where is Cancer Diagnosis and Treatment research done?

The largest centres of Cancer Diagnosis and Treatment research in 2022-now are New York (United States), Tokyo (Japan), Beijing (China) and London (United Kingdom).

Largest cities, 2022-now

  1. 1 New YorkUnited States 79 works
  2. 2 TokyoJapan 79 works
  3. 3 BeijingChina 79 works
  4. 4 LondonUnited Kingdom 70 works
  5. 5 SeoulSouth Korea 59 works
  6. 6 MoscowRussia 59 works
  7. 7 ShanghaiChina 58 works
  8. 8 HoustonUnited States 54 works
  9. 9 IstanbulTürkiye 53 works
  10. 10 New DelhiIndia 53 works
See Cancer Diagnosis and Treatment on the map

Where is the best place to study Cancer Diagnosis and Treatment?

Among universities, judged by research, Harvard University, University of California, San Francisco and Heidelberg University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 20.71%fractional works in this field (log) →share of work in the world top 10% →University of Califo…Harvard UniversityHeidelberg UniversityUniversity of Toronto
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 72.623.8%2.6×45 -21.9%
2University of California, San FranciscoUnited States 62.427.4%3.7×14 +8.0%
3Heidelberg UniversityGermany 59.221.0%3.8×16 +10.2%
4University of TorontoCanada 57.319.0%1.6×17 -6.3%
5Johns Hopkins UniversityUnited States 55.822.1%1.9×16 -11.1%
6All India Institute of Medical SciencesIndia 55.46.0%9.0×53 +6.1%
7Case Western Reserve UniversityUnited States 54.615.2%5.1×16 +9.9%
8Sungkyunkwan UniversitySouth Korea 54.621.7%3.3×12 +18.8%
9Università Cattolica del Sacro CuoreItaly 54.120.9%5.2×12 +35.3%
10University of British ColumbiaCanada 54.130.0%1.4×9 -13.5%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Cancer Diagnosis and Treatment, country by country

Is Cancer Diagnosis and Treatment research growing?

Output in 2022-2025 was 9% lower than in 2018-2021, peaking in 2020.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cancer Diagnosis and Treatment as a percentage of every work published that year, 0.029% in 2024.

still counting0.050%0.10%Cancer Diagnosis and Treatment0.022% in 202519801990200020102020

Fractional works of Cancer Diagnosis and Treatment over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Cancer Diagnosis and Treatment10.6% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Cancer Diagnosis and Treatment. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.